Evrofarma SA (ATH:EVROF)

Evrofarma Revenue

Evrofarma had revenue of 26.47M EUR in the half year ending June 30, 2026, with 22.29% growth. This brings the company's total for the last twelve months to 51.59M, up 6.59% year-over-year. In the year 2025, Evrofarma had annual revenue of 49.44M with 8.14% growth. That makes Evrofarma the 26,847th largest company in the world by revenue and 72nd in Greece.

• Revenue (ttm): 51.59M
• Revenue Growth: +6.59%
• P/S Ratio: 0.99
• Revenue / Employee: 257.94K
• Employees: 200
• Market Cap: 50.83M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Parent Company-Production and Sales of Dairy Products 44.15M 80.8%
• Subsidiary-Cattle Farming 10.48M 19.2%

By Geography

Chart

• Greece 36.54M 73.9%
• European Union Countries 10.99M 22.2%
• Third Countries 1.94M 3.9%

Fiscal year ended Dec 31, 2025 See the full Evrofarma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.44M	3.72M	8.14%
Dec 31, 2024	45.72M	-3.04M	-6.24%
Dec 31, 2023	48.76M	3.38M	7.45%
Dec 31, 2022	45.38M	8.68M	23.66%
Dec 31, 2021	36.70M	2.79M	8.23%

Data Source: S&P Global Market Intelligence Last updated: Sep 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error